Latest Period
Q2 2026
Security Snapshot
Legend Biotech Corp - COMMON STOCK (LEGN) Institutional Ownership
CUSIP: 52490G102
13F Institutional Holders and Ownership History from Q2 2020 to Q2 2026
Institutions Reporting
218
Shares (Excl. Options)
103,044,706
Price
$28.88
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- LEGN on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 103,044,706
- Total 13F value
- $2,976,124,281
- Portfolio coverage rank
- 0.01%
- Share change
- +6,974,459
- Value change
- +$257,672,654
- Number of holders
- 218
- Shares outstanding
- 386,641,322
- SEC-reported price per share
- $23.53
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- LEGN - Legend Biotech Corp - COMMON STOCK is tracked under CUSIP 52490G102.
- 218 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 191 to 218 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,737,725,576 to $2,976,124,281.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 218 institutions filings for Q2 2026.
Security key
52490G102
Latest holder period
Q2 2026
13F holders
218
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
LEGN full holder history
Legend Biotech Corp SEC filings
Legend Biotech Corp company facts
Legend Biotech Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 52490G102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
LEGN
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 15% | +15% | $1,493,402,108 | +$249,820,140 | 57,996,198 | +20% | FMR LLC | 30 Jun 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3.7% | $233,379,028 | 6,808,023 | T. Rowe Price Associates, Inc. | 31 Dec 2024 |
As of 30 Jun 2026, 218 institutional investors reported holding 103,044,706 shares of Legend Biotech Corp - COMMON STOCK (LEGN). This represents 27% of the company’s total 386,641,322 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| FMR LLC | 7.5% | 29,093,899 | +13% | 0.04% | $840,231,809 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 2.1% | 8,137,638 | +5.9% | 2.5% | $235,014,985 |
| MONTANOVA CAPITAL, LLC | 1.8% | 7,070,000 | -6.7% | 4.3% | $204,181,600 |
| HHLR ADVISORS, LTD. | 1.5% | 5,984,550 | 0% | 21% | $172,833,804 |
| BlackRock, Inc. | 1.2% | 4,726,534 | +0.9% | 0% | $136,502,311 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1.1% | 4,430,063 | -23% | 0.42% | $127,940,224 |
| GOLDMAN SACHS GROUP INC | 0.95% | 3,662,315 | +150% | 0.01% | $105,767,658 |
| Point72 Asset Management, L.P. | 0.8% | 3,076,124 | -21% | 0.14% | $88,838,461 |
| Kynam Capital Management, LP | 0.78% | 3,001,205 | +90% | 4.8% | $86,674,800 |
| Assenagon Asset Management S.A. | 0.5% | 1,915,056 | 0.07% | $55,306,817 | |
| Artisan Partners Limited Partnership | 0.4% | 1,559,441 | -31% | 0.07% | $45,036,656 |
| STATE STREET CORP | 0.39% | 1,498,704 | +0.02% | 0% | $43,291,671 |
| Capital International Investors | 0.37% | 1,420,654 | +119% | 0.01% | $41,028,488 |
| MORGAN STANLEY | 0.36% | 1,394,531 | +131% | 0% | $40,274,080 |
| Soleus Capital Management, L.P. | 0.31% | 1,205,000 | 1.2% | $34,800,400 | |
| Davern Capital Partners, LP | 0.31% | 1,191,522 | -9.4% | 5.9% | $34,411,155 |
| Driehaus Capital Management LLC | 0.3% | 1,158,808 | 0.19% | $33,466,375 | |
| RENAISSANCE TECHNOLOGIES LLC | 0.26% | 1,000,200 | +92% | 0.04% | $28,885,776 |
| Ghisallo Capital Management LLC | 0.26% | 1,000,000 | 0.57% | $28,880,000 | |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 0.24% | 917,266 | -0.93% | 9.1% | $26,490,642 |
| JOHNSON & JOHNSON | 0.21% | 814,586 | 0% | 2.9% | $23,525,244 |
| IvyRock Asset Management (HK) Ltd | 0.21% | 801,000 | -0.37% | 13% | $23,132,880 |
| EcoR1 Capital, LLC | 0.21% | 800,000 | 1.1% | $23,104,000 | |
| Squarepoint Ops LLC | 0.2% | 769,252 | +60% | 0.04% | $22,215,998 |
| JPMORGAN CHASE & CO | 0.2% | 766,364 | +166% | 0% | $22,523,437 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
25
Latest
Q2 2026
Rows shown
1-25 of 25
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 103,044,706 | $2,976,124,281 | +$257,672,654 | $28.88 | 218 |
| 2026 Q1 | 96,070,629 | $1,737,725,576 | +$133,064,401 | $18.09 | 191 |
| 2025 Q4 | 87,590,794 | $1,903,821,672 | +$15,027,480 | $21.74 | 197 |
| 2025 Q3 | 83,685,243 | $2,727,887,108 | -$49,026,070 | $32.61 | 198 |
| 2025 Q2 | 84,637,633 | $3,002,800,929 | -$25,701,898 | $35.49 | 209 |
| 2025 Q1 | 85,585,612 | $2,906,390,112 | -$451,293,431 | $33.93 | 205 |
| 2024 Q4 | 99,259,008 | $3,230,144,565 | +$188,311,867 | $32.54 | 205 |
| 2024 Q3 | 91,083,902 | $4,438,353,408 | +$43,810,918 | $48.73 | 204 |
| 2024 Q2 | 91,534,759 | $4,053,943,715 | +$152,693,975 | $44.29 | 173 |
| 2024 Q1 | 86,480,093 | $4,850,469,897 | +$24,114,634 | $56.09 | 187 |
| 2023 Q4 | 85,815,138 | $5,163,245,741 | -$85,151,940 | $60.17 | 204 |
| 2023 Q3 | 85,989,090 | $5,775,420,098 | +$112,052,258 | $67.17 | 198 |
| 2023 Q2 | 84,064,242 | $5,802,906,378 | +$1,140,343,215 | $69.03 | 191 |
| 2023 Q1 | 68,026,089 | $3,279,762,243 | +$214,876,512 | $48.22 | 158 |
| 2022 Q4 | 63,494,614 | $3,169,508,515 | -$28,958,118 | $49.92 | 167 |
| 2022 Q3 | 63,810,382 | $2,603,349,501 | +$399,712,134 | $40.80 | 154 |
| 2022 Q2 | 52,707,652 | $2,898,825,468 | +$118,361,366 | $55.00 | 147 |
| 2022 Q1 | 51,010,221 | $1,853,796,102 | +$18,669,383 | $36.34 | 137 |
| 2021 Q4 | 50,201,932 | $2,340,358,513 | +$500,109,001 | $46.61 | 137 |
| 2021 Q3 | 39,005,848 | $1,971,657,000 | +$572,564,727 | $50.56 | 87 |
| 2021 Q2 | 28,328,593 | $1,162,838,000 | +$121,639,656 | $41.05 | 84 |
| 2021 Q1 | 26,391,052 | $765,864,420 | +$30,109,528 | $29.02 | 69 |
| 2020 Q4 | 25,444,505 | $716,732,000 | +$16,894,703 | $28.16 | 60 |
| 2020 Q3 | 24,479,702 | $752,680,000 | -$30,044,903 | $30.87 | 50 |
| 2020 Q2 | 24,613,241 | $1,036,097,000 | +$1,036,097,000 | $42.56 | 76 |